Info Edge, Intel, SoftBank and Tencent are all in line for exits as PolicyBazaar files for an initial public offering in India.

Mitsui and Nan Fung are among the backers celebrating Rallybio’s flotation on the Nasdaq Global Select Market following an $80.6m offering.

The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.

The Sanofi Ventures-backed vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

The transport provider is merging with publicly-listed Queen's Gambit Growth Capital at a $1.5bn valuation, with Zain and Agility both investing.

Ant Group-backed mobility serices provider has cancelled its initial public offering in the wake of regulatory crackdowns in its home country of China.

The Verizon-backed programmatic advertising software provider is joining forces with Nasdaq-listed CAP Acquisition Corporation.

IN8Bio, a University of Alabama spinout and cancer immunotherapy developer, has pulled in $40m through its IPO.

The Tencent-backed game publisher priced its shares at the top of their range in an offering set to take place on August 10 that will value it at $21.2bn.

Alphabet and Roc Nation-backed share and crypto trading platform developer RobinHood floated at the bottom of its range but still raised almost $2.1bn.